App coaching parents to reduce children's exposure to second-hand smoke
Tests a smoking-reduction app for parents of children up to 5 years old.
Plain-language title generated from the registry record
Registry title: Early Life Intervention in Pediatrics Supported by E-health - SMOKE
Key facts
- Where
- Bern, SwitzerlandSee the site
Where in Switzerland
- Department of Paediatrics, Inselspital, Bern University HospitalBern, SwitzerlandTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Insel Gruppe AG, University Hospital Bern
- Trial code
- NCT06311162
- Record updated
- 6 May 2026
- Original description
Unrestricted parental smoking habits are lifestyle risk behaviors associated with chronic, systemic inflammation, which promotes the pathogenesis of non-communicable diseases (NCDs). Exposure to secondhand tobacco smoke in early life contributes to the development of specific NCDs in children, i.e. asthma. Early preventive measures to improve lifestyle behavior in parents are therefore of utmost importance. The aim of ELIPSE-II is to assess whether an eHealth application intervention for parents is feasible and efficacious in lowering levels of urinary cotinine as a measure of second-hand smoke exposure in their children .Read full original descriptionShow less
Early Life Intervention in Pediatrics Supported by E-health (ELIPSE II): Coaching Parents to Lower Second-hand Smoke Exposure in Children A Single-blind Randomized Controlled Parallel-group Clinical Trial
Unrestricted parental smoking habits are lifestyle risk behaviors associated with chronic, systemic inflammation, which promotes the pathogenesis of non-communicable diseases (NCDs). Exposure to secondhand tobacco smoke in early life contributes to the development of specific NCDs in children, i.e. asthma. Early preventive measures to improve lifestyle behavior in parents are therefore of utmost importance. The aim of ELIPSE-II is to assess whether an eHealth application intervention for parents is feasible and efficacious in lowering levels of urinary cotinine as a measure of second-hand smoke exposure in their children .
Inclusion: Age: younger than 6 years; Exposed to second-hand smoke at home (at least one parent smoking); German speaking parent; All sex and ethnic backgrounds; Signed informed consent form from parent; Children live/grow-up in the same household as the parental participant; Referred by a health care professional (e.g. physician, midwife, nurse, other professions).
Exclusion: Participation in another study/trial targeting similar outcomes; Participation in an active smoking cessation programme.